Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. [electronic resource]
Producer: 20140925Description: 204-10 p. digitalISSN:- 1528-0020
- ADAM Proteins -- blood
- ADAMTS13 Protein
- Adult
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Autoantibodies -- blood
- Chemoprevention -- methods
- Cross-Sectional Studies
- Female
- Humans
- Infusions, Intravenous
- Male
- Purpura, Thrombotic Thrombocytopenic -- blood
- Remission Induction
- Retrospective Studies
- Rituximab
- Secondary Prevention
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.